• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜间皮瘤的生存预测:基于 SEER 数据和中国队列的列线图。

Survival prediction in peritoneal mesothelioma: a nomogram based on SEER data and a Chinese cohort.

机构信息

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

出版信息

Front Endocrinol (Lausanne). 2024 Sep 6;15:1432787. doi: 10.3389/fendo.2024.1432787. eCollection 2024.

DOI:10.3389/fendo.2024.1432787
PMID:39309108
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11412845/
Abstract

OBJECTIVE

This study aimed to develop nomogram predicting overall survival (OS) of patients with peritoneal mesothelioma (PeM) using data from Surveillance, Epidemiology, and End Results (SEER) database and a Chinese institution.

METHODS

1,177 PeM patients from the SEER database were randomized into training and internal validation cohorts at a 7:3 ratio. An external validation cohort consisting of 109 patients was enrolled from a Chinese institution. Nomogram was constructed based on variables identified through multivariate Cox regression analysis and evaluated by consistency indices (C-index), calibration plots, and receiver operating characteristic (ROC) curves. Patients were stratified into different risk categories, and Kaplan-Meier survival analysis was used to assess OS differences among these groups.

RESULTS

The nomogram, incorporating age, gender, histological type, T stage, M stage, and surgical status, demonstrated strong predictive capability with C-index values of 0.669 for the training cohort, 0.668 for the internal validation cohort, and 0.646 for the external validation cohort. The nomogram effectively stratified patients into high-risk and low-risk groups, with the high-risk group exhibiting significantly poorer OS (P < 0.05). Multivariate analysis confirmed gender, age, surgical intervention, and M stage as independent prognostic factors (P < 0.05). Specifically, male gender, older age, and unspecified M stage were linked to worse outcomes, while surgical intervention was associated with improved survival.

CONCLUSION

The nomogram provide a reliable tool for predicting the survival in PeM patients, facilitating more informed treatment decisions. Key independent prognostic factors include gender, age, surgical intervention, and M stage.

摘要

目的

本研究旨在使用来自 SEER 数据库和一家中国机构的数据,开发预测腹膜间皮瘤(PeM)患者总生存期(OS)的列线图。

方法

将 SEER 数据库中的 1177 例 PeM 患者随机分为训练队列和内部验证队列,比例为 7:3。从一家中国机构招募了 109 例患者组成外部验证队列。基于多变量 Cox 回归分析确定的变量构建列线图,并通过一致性指数(C 指数)、校准图和接受者操作特征(ROC)曲线进行评估。将患者分为不同的风险类别,并使用 Kaplan-Meier 生存分析评估这些组之间的 OS 差异。

结果

该列线图纳入了年龄、性别、组织学类型、T 分期、M 分期和手术状态,在训练队列中的 C 指数为 0.669,内部验证队列中的 C 指数为 0.668,外部验证队列中的 C 指数为 0.646,具有较强的预测能力。该列线图能够有效地将患者分为高风险和低风险组,高风险组的 OS 明显较差(P<0.05)。多变量分析证实性别、年龄、手术干预和 M 分期是独立的预后因素(P<0.05)。具体而言,男性、年龄较大和未明确的 M 分期与较差的结局相关,而手术干预与生存改善相关。

结论

该列线图为预测 PeM 患者的生存提供了可靠的工具,有助于做出更明智的治疗决策。关键的独立预后因素包括性别、年龄、手术干预和 M 分期。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a042/11412845/02909db27eea/fendo-15-1432787-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a042/11412845/16bb8108a1cb/fendo-15-1432787-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a042/11412845/a4d57375985a/fendo-15-1432787-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a042/11412845/daabe7b6606d/fendo-15-1432787-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a042/11412845/f0de76d49991/fendo-15-1432787-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a042/11412845/02909db27eea/fendo-15-1432787-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a042/11412845/16bb8108a1cb/fendo-15-1432787-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a042/11412845/a4d57375985a/fendo-15-1432787-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a042/11412845/daabe7b6606d/fendo-15-1432787-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a042/11412845/f0de76d49991/fendo-15-1432787-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a042/11412845/02909db27eea/fendo-15-1432787-g005.jpg

相似文献

1
Survival prediction in peritoneal mesothelioma: a nomogram based on SEER data and a Chinese cohort.腹膜间皮瘤的生存预测:基于 SEER 数据和中国队列的列线图。
Front Endocrinol (Lausanne). 2024 Sep 6;15:1432787. doi: 10.3389/fendo.2024.1432787. eCollection 2024.
2
Survival analysis via nomogram of surgical patients with malignant pleural mesothelioma in the Surveillance, Epidemiology, and End Results database.基于监测、流行病学和最终结果数据库中外科治疗恶性胸膜间皮瘤患者的列线图生存分析。
Thorac Cancer. 2019 May;10(5):1193-1202. doi: 10.1111/1759-7714.13063. Epub 2019 Apr 5.
3
[Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data].[建立预后列线图并探讨宫颈腺癌的最佳治疗方案:一项基于SEER数据库和中国单中心数据的回顾性研究]
Zhonghua Fu Chan Ke Za Zhi. 2024 Apr 25;59(4):307-319. doi: 10.3760/cma.j.cn112141-20231101-00172.
4
The Nomogram predicting the overall survival of patients with pancreatic cancer treated with radiotherapy: a study based on the SEER database and a Chinese cohort.基于 SEER 数据库和中国队列研究的列线图预测胰腺癌患者放疗后总生存的研究。
Front Endocrinol (Lausanne). 2023 Oct 25;14:1266318. doi: 10.3389/fendo.2023.1266318. eCollection 2023.
5
Constructing a Nomogram for Predicting Pelvic Osteosarcoma: A Retrospective Study Based on the SEER Database and a Chinese Cohort.构建基于 SEER 数据库和中国队列的骨盆骨肉瘤预测列线图:一项回顾性研究。
Br J Hosp Med (Lond). 2024 Aug 30;85(8):1-17. doi: 10.12968/hmed.2024.0339.
6
Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.基于监测、流行病学和最终结果(SEER)数据库预测直肠鳞状细胞癌患者总生存期的列线图:一项基于人群的加强观察性研究报告(STROBE)队列研究
Medicine (Baltimore). 2019 Nov;98(46):e17916. doi: 10.1097/MD.0000000000017916.
7
A prognostic nomogram and risk classification system of elderly patients with extraosseous plasmacytoma: a SEER database analysis.基于 SEER 数据库分析的老年骨外浆细胞瘤患者预后列线图和风险分级系统。
J Cancer Res Clin Oncol. 2023 Dec;149(20):17921-17931. doi: 10.1007/s00432-023-05492-6. Epub 2023 Nov 13.
8
Establishment and validation of nomograms to predict survival probability of advanced malignant pleural mesothelioma based on the SEER database and a Chinese medical institution.基于 SEER 数据库和一家中国医疗机构建立并验证预测晚期恶性胸膜间皮瘤生存概率的列线图。
Front Endocrinol (Lausanne). 2023 Apr 14;14:1139222. doi: 10.3389/fendo.2023.1139222. eCollection 2023.
9
A prognostic framework for predicting lung signet ring cell carcinoma via a machine learning based cox proportional hazard model.基于机器学习的 Cox 比例风险模型预测肺印戒细胞癌的预后框架。
J Cancer Res Clin Oncol. 2024 Jul 25;150(7):364. doi: 10.1007/s00432-024-05886-0.
10
Survival nomograms for vulvar squamous cell carcinoma based on the SEER database and a Chinese external validation cohort.基于 SEER 数据库和中国外部验证队列的外阴鳞癌生存列线图。
Int J Gynaecol Obstet. 2024 Jun;165(3):1130-1143. doi: 10.1002/ijgo.15313. Epub 2024 Jan 19.

引用本文的文献

1
Identification of the high-risk population facing early death in older patients with primary intracranial glioma: a retrospective cohort study.原发性颅内胶质瘤老年患者早期死亡高危人群的识别:一项回顾性队列研究。
Front Endocrinol (Lausanne). 2025 Mar 3;16:1546530. doi: 10.3389/fendo.2025.1546530. eCollection 2025.

本文引用的文献

1
Establishment and validation of nomograms to predict survival probability of advanced malignant pleural mesothelioma based on the SEER database and a Chinese medical institution.基于 SEER 数据库和一家中国医疗机构建立并验证预测晚期恶性胸膜间皮瘤生存概率的列线图。
Front Endocrinol (Lausanne). 2023 Apr 14;14:1139222. doi: 10.3389/fendo.2023.1139222. eCollection 2023.
2
Contemporary Trends in Malignant Peritoneal Mesothelioma: Incidence and Survival in the United States.恶性腹膜间皮瘤的当代趋势:美国的发病率和生存率
Cancers (Basel). 2022 Dec 30;15(1):229. doi: 10.3390/cancers15010229.
3
Establishment of predictive nomogram and web-based survival risk calculator for malignant pleural mesothelioma: A SEER database analysis.
恶性胸膜间皮瘤预测列线图及基于网络的生存风险计算器的建立:一项监测、流行病学和最终结果(SEER)数据库分析
Front Oncol. 2022 Oct 7;12:1027149. doi: 10.3389/fonc.2022.1027149. eCollection 2022.
4
Prognostic factors of malignant peritoneal mesothelioma: a retrospective study of 52 female patients.恶性腹膜间皮瘤的预后因素:52 例女性患者的回顾性研究。
World J Surg Oncol. 2022 Jun 29;20(1):219. doi: 10.1186/s12957-022-02688-x.
5
Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial.纳武利尤单抗对比安慰剂治疗复发恶性间皮瘤患者(CONFIRM):一项多中心、双盲、随机、III 期临床试验。
Lancet Oncol. 2021 Nov;22(11):1530-1540. doi: 10.1016/S1470-2045(21)00471-X. Epub 2021 Oct 14.
6
Malignant Mesothelioma.恶性间皮瘤
Cancers (Basel). 2021 Jul 9;13(14):3447. doi: 10.3390/cancers13143447.
7
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial.一线纳武利尤单抗联合伊匹单抗治疗不可切除恶性胸膜间皮瘤(CheckMate 743):一项多中心、随机、开放标签、III 期临床试验。
Lancet. 2021 Jan 30;397(10272):375-386. doi: 10.1016/S0140-6736(20)32714-8. Epub 2021 Jan 21.
8
Peritoneal mesothelioma.腹膜间皮瘤
Transl Lung Cancer Res. 2020 Feb;9(Suppl 1):S120-S132. doi: 10.21037/tlcr.2019.12.15.
9
Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy.遗传性恶性间皮瘤倾向与铂类化疗后的总生存期。
Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):9008-9013. doi: 10.1073/pnas.1821510116. Epub 2019 Apr 11.
10
Prognostic Factors of Malignant Peritoneal Mesothelioma Experienced in Japanese Peritoneal Metastasis Center.日本腹膜转移中心所经历的恶性腹膜间皮瘤的预后因素
Gan To Kagaku Ryoho. 2019 Feb;46(2):395-399.